MedTrace Logo

Observational Copenhagen Pancreatic Cancer Study

NCT06713525 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2024-12-03

No results posted yet for this study

Summary

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Conditions

Sponsors & Collaborators

  • Inna Chen, MD

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2035-12-31
Completion
2036-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06713525 on ClinicalTrials.gov